I will now turn you over to Patrick Dear to commence the presentation. Patrick Dear? As one of the Principals and Founders of the Investment manager of Tetragon Financial Group Limited, I'd like to welcome you all to our Investor call, which will focus on the Company's 2025 first half results. Paul Gannon, our CFO and COO, will review the company's financial performance for the period. Stephen Prince and I will talk you through some of the detail of the portfolio and that performance. Stephen Prince will spend some time discussing the outlook. As usual, we'll conclude with questions, those taken electronically via our web-based system at the end of the presentation, as well as those received since the last update. The PDF of the slides is now available to download on our website, and if you're on the webcast, directly from the webcast portal. Before I go into the presentation, some reminders. First, Tetragon shares are subject to restrictions on ownership by U.S. persons and are not intended for European retail investors. These are described in some detail on our website. Tetragon anticipates that its typical investors will be institutional and professional investors who wish to invest for the long term and who have experience in investing in financial markets and collective investment undertakings, who are capable themselves of evaluating the merits and risks of Tetragon shares and who have sufficient resources both to invest in potentially illiquid securities and to be able to bear any losses that may result from the investment, which may equal the whole of the amount invested. I'd like to remind everyone that the following may contain forward-looking comments, including statements regarding the intentions, beliefs, or current expectations concerning performance and the financial condition on the products and markets in which Tetragon invests. Our performance may change materially as a result of various possible events or factors. With that introduction, let me pass you over to Paul. Thanks, Patrick Dear. Tetragon continues to focus on three key metrics when assessing how value is being created for and delivered to Tetragon shareholders. Firstly, how value is being created via NAV per share total return. Secondly, how investment returns are contributing to value creation, measured as a return on equity or ROE. Finally, how value is being returned to shareholders through distributions, mainly in the form of dividends. The fully diluted NAV per share was $38.74 as of June 30, 2025. The NAV per share total return was 10% for the first half of 2025. Since its IPO in 2007, Tetragon has achieved an annualized NAV per share total return of 11%. For monitoring investment returns, we use an ROE calculation, which was positive 12.2% for the first half of 2025, net of all fees and expenses. For comparison purposes, our target for a six-month period would be 5% to 7.5%, very significantly above. The average annual ROE achieved since IPO is now 11.8%, which is within the target range of 10% to 15%. Looking at the final key metric, Tetragon declared a dividend of $0.11 for the second quarter, which represents a dividend of $0.22 year to date. Based on the quarter-end share price of $16.15, the last four quarters' dividend represents a yield of approximately 2.7%. This next slide shows a NAV bridge breaking down into its component parts the change in Tetragon's fully diluted NAV per share, which started the period at $35.43 and ended at $38.74 per share. Investment income increased NAV per share by $5.95 per share. Operating expenses, management, and incentive fees reduced NAV per share by $1.52, with a further $0.14 per share reduction due to interest expense incurred on the revolving credit facility. On the capital side, gross dividends reduced NAV per share by $0.22. There was also a net dilution of $0.76 per share, which is labeled as other share dilution. This bucket primarily reflects the impact of dilution from stock dividends plus the additional recognition of equity-based compensation shares. I will now hand back over to Patrick Dear. Thanks, Paul. As on previous calls, before we delve into the details of our performance for the period, I'd like to put the company's performance in the context of the long term. Tetragon began trading in 2005 and became a public company in April 2007. The fund now has 20 years of trading history. What this chart shows is the NAV per share total return, which is the thick green line at the top, the share price total return, which is the dash green line, which is the next one. All of this is since IPO. The chart also includes equity indices, the MSCI ACWI, and the FTSE All- Share. Lastly, it includes the hurdle rate that Tetragon has of SOFR plus 2.75%. As you can see in the graph, over the time that Tetragon has been trading as a publicly listed company, our NAV per share total return is 572%. We do believe that our somewhat idiosyncratic structure, that is, of a listed fund owning alternative assets and a diversified alternative asset management platform, enables us to create an alpha-driven ecosystem of ideas, expertise, insights, and connections that helps us to generate investment returns. Moving to the next slide, but continuing the theme of looking at the long term, here are some more performance metrics. Our ROE, or investment return for the first half, as Paul has said, is 12.2%. That's for the half year and compares with our full year target of 10% to 15% per annum over the cycles. We've averaged an annual return since IPO of 11.8%. Thus, as Paul mentioned, the first half performance is an outlier, but in a very positive sense. The table also shows on the top right-hand side that just over 38% of the public shares are owned by principals of the investment manager and employees of TFG Asset Management. We believe that this is a very important metric as it demonstrates a strong belief in what we do, as well as a strong alignment of interest between the manager, TFG Asset Management employees, and Tetragon shareholders. This next slide shows a breakdown of the $3.5 billion of net asset value by the various different asset classes. What these colored discs do is show the percentage breakdown of the asset classes and strategies as at year-end 2024 on the left, and you can compare them with the end of the first half of 2025 on the right. I would note three changes. First, Tetragon's investment in private equity stakes in asset management companies, collectively known as TFG Asset Management, has moved up from 45% of NAV to 48%, mainly driven by an increased valuation in Equitix. Secondly, private equity and venture capital are at 23% versus 22%, driven by gains in Ripple Labs and Hawke's Point. Other asset classes have moved down and mainly pro rata. Investments in event-driven equities and convertibles, which we own through hedge funds, decreased to 15% from 17%. Equally, bank loans have continued to decrease down from 5% to 3%. Perhaps it's worth a slight pause at that last point. Many people have thought of Tetragon in the past as a CLO business. Just to reiterate, bank loans in total as an asset class are roughly 3% of Tetragon's NAV. That's down from probably about 95% at IPO 18 years ago. Moving to the next slide, let's move to discuss the performance in a little more detail. The NAV bridge that Paul showed was a high-level overview of the NAV per share. This table shows a breakdown of the composition of Tetragon's NAV at the end of 2024 versus the NAV at the end of the first half of 2025. It does it by asset classes and therefore, the factors contributing to the change in NAV. Thus, this table shows investment performance plus the capital flows, tying back to the change in NAV. As you can see from the bottom row of the table, the aggregate investment performance labeled gains and losses, so that fourth column, was a gross profit for the period of $540 million. There were three large drivers of this return, all of which were a continuation of the performance that we saw in 2024. The first is $409 million of profit came from our ownership in Equitix, our infrastructure asset manager. Second, $118 million came from the direct private equity investments, mainly from our investment in Ripple Labs, a private blockchain and crypto business that supports the XRP Ledger. Thirdly, $63 million from an Australian gold mining company, which is an investment in a Hawke's Point fund. As I said at year-end, but I'm happy to reiterate, it's hard to imagine three less intrinsically correlated investments. These three investments exemplify, in a way, our diversified approach and our focus on identifying attractive alternative investment strategies that may be more likely to have low correlation both to markets and ideally to each other. Now, to take you through the asset classes in a little more detail, you can see that for TFG Asset Management, our private equity holdings in asset management companies, the total gains are $365 million. These asset management businesses continue to grow and perform well. This is the best-performing segment, and obviously, that includes Equitix. The hedge fund strategies, event-driven equities, convertibles, and other hedge funds gained $6.5 million. Bank loans, and these are held through CLOs, had a loss for the first half of $24 million. Real estate had a loss of $8.5 million. Private equity and venture capital had a gain of $189 million. This includes the Hawke's Point funds and Ripple Labs as a direct private equity investment. Legal assets had a gain of $3 million. Lastly, other equities and credit had a gain of $8 million. Now, what we'd like to do is take more detail on each category. Let's start with TFG Asset Management, our private equity investments in asset management companies. To do that, I'd like to pass over to Stephen Prince. Thanks, Patrick Dear. Before I review the performance of TFG Asset Management's constituent businesses, I wanted to take a moment to remind listeners of TFG Asset Management's strategy and key value proposition. Our investment objective continues to be to generate distributable income and capital appreciation. We do this by seeking to generate stable returns across economic cycles and market conditions. We continue to look to add new strategies and help individuals and teams to create successful asset management businesses by leveraging TFG Asset Management's operating infrastructure and shared strategic direction with Tetragon, who can support asset management businesses through co-investment and working capital. At the same time, we continue to look for creative ways to help our partners grow their existing businesses, which may involve selling partial stakes or whole businesses if we and they believe it may unlock future growth and value. I'll speak more about this in a moment when we discuss Equitix. Now, I'm going to move on to the performance of our asset managers during the first half of 2025. Our private equity investments in asset management companies through TFG Asset Management recorded an investment gain of $365 million during the period, driven by investments in Equitix and integrated core infrastructure asset management and primary project platform. In June, Tetragon announced that Hunter Point Capital, or HPC, has agreed to acquire a minority stake in Equitix. HPC is acquiring a 16.1% stake in the business at an implied enterprise value of £1.3 billion before accounting for net debt. HPC's stake is being acquired from two existing shareholders, approximately 14.6% from TFG Asset Management and 1.5% from Equitix Management. The deal is subject to customary closing conditions, including required regulatory approvals. After the deal, Tetragon will continue to hold 66.4% of Equitix. Tetragon's investment made a gain of $409 million during the first half of the year. That was driven by a combination of, A, a higher valuation as the valuation approaches were calibrated towards the HPC transaction; B, foreign exchange gains as the pound gained 9.6% against the dollar. As a reminder, 50% of the value of our holding in Equitix is hedged; and C, dividend income of $9.4 million received from Equitix. The transaction that Tetragon consummated with Hunter Point allows us to realize some of the value created in the business, but also to remain invested with a trusted partner in Equitix in a sector where we continue to see significant runway for innovation and growth. Lastly, the transaction allows us to partner with a firm, Hunter Point, whom we think will help us enhance the value of Equitix. Moving on to other investments. BentallGreenOak, our real estate-focused investing firm, had an investing gain of $28.3 million during the first half. Distributions to Tetragon during the period totaled $9.2 million, reflecting a combination of fixed quarterly contractual payments and variable payments. The valuation of BentallGreenOak is on a discounted cash flow basis with an assumed exit upon the exercise of our put call option in 2026-2027. The exercise price will be determined based on the average EBITDA of BentallGreenOak during the two years prior to exercising the option. The main driver of the investment gain was an increase in the value of the put call option due to a higher EBITDA achieved than previously forecast, as well as an unwinding of the discount at which we hold the investment. LCM Advisors, our CLO manager, had AUM of $7.7 billion as of the end of the first half of the year, which was 12% lower than the end of 2024, when the AUM was $8.8 billion. That was due to an amortization of the existing deals. Tetragon's investment in LCM Advisors made a loss of $35.3 million as the valuation reflected the impact of the reduction in the AUM. As a reminder, Tetragon's other asset management businesses include Westbourne River Partners, which is an alternative asset manager focused on event-driven investing in European small and mid-cap equities; Acasta Partners, an alternative asset manager employing a multidisciplinary approach; Tetragon Credit Partners, a structured credit investing business focused primarily on primary CLO control equity. I should point out during the first quarter of 2025, Tetragon Credit Partners did have its first close in Tetragon Credit Income Fund 5. Hawke's Point, an asset management business that provides strategic capital to companies in the resource sector; Bain & Square Partners, a private equity firm focused on non-control equity investment opportunities and opportunistic investments in public equity and credit investments; and Contingency Capital, a global asset management business focused on credit-oriented legal assets. The collective loss on Tetragon's investments in these managers, as well as a platform, was $37 million during the first half of the year. That was owing to a combination of a reduction in the fair value of some of these managers, as well as working capital contributed to support some of the relatively nascent businesses. I'm now going to turn the call back over to Patrick Dear, who's going to review our hedge fund investments. Thanks, Stephen Prince. Tetragon invests in event-driven equities, convertible bonds, credit, and other strategies through hedge funds. The majority of these investments are through funds managed by Westbourne River Partners and Acasta Partners. Both of those are part of TFG Asset Management, where the management company is owned partially or fully by Tetragon. Our investment in the Westbourne River European event-driven strategies recorded a gain of $5 million in the first half. For context, the net performance for the funds was positive 6.5% for the long-biased share class and positive 0.8% for the low-net share class. Investments in Acasta Partners funds generated a gain of $2.8 million. For context, the net performance for the Acasta Global Fund was plus 2.3% for its flagship share class. Investments in other hedge funds, including the Global Equity Fund, had a loss of $1.3 million during the period and remain a small portion of the portfolio. Moving on to bank loans, Tetragon predominantly invests in bank loans through CLOs, taking majority positions in the equity classes. Tetragon's investments are split, as shown here, between those directly owned U.S. CLOs, which are generally managed by LCM Advisors, and the funds managed by Tetragon Credit Partners. As I said earlier, it's worth noting that our exposure has dropped to under 3% of the total NAV. In aggregate, our bank loan investments recorded a loss of $24 million for the first half in 2025. That is after receiving cash during the period of approximately $30 million. New investments were approximately $1 million. CLO performance during the period was negatively impacted by realized and unrealized losses on certain older vintage loan exposures. Next is real estate. Tetragon holds most of its investments in real estate through BentallGreenOak-managed funds and co-investment vehicles. The majority of these are private equity style, concentrating on opportunistic investments targeting middle-market opportunities in the U.S., Europe, and Asia, with particular focus on growth sectors such as logistics, data centers, and cold storage. These funds had a net loss of $8.5 million during the period. Losses continue to stem from the U.S.-focused funds, mainly due to exposure to commercial, residential, and hotels. The losses were slightly offset by gains in Europe. Cash received from fund distributions during the period was $1 million, and new investments made were $7 million. Lastly, the other real estate is farmland investment in Paraguay. This is managed by a specialist third-party manager in South American farmland, and the investment was flat after a third-party revaluation. Now I'll hand you back to Stephen Prince. Thanks, Patrick Dear. Tetragon's private equity and venture capital investments were the top driver of performance during the first half. They generated gains of $189 million. Investments in this category are split in the following subcategories. The top driver was in the direct private equity bucket, which produced gains of $118 million related to Tetragon's investment in the Series A and B preferred stock of Ripple Labs, a top U.S. enterprise blockchain company underpinned by the XRP token and XRPL cryptocurrency ledger. Ripple announced a tender offer in June 2025 at a purchase price of $175 a share, in which Tetragon participated. The tender closed in July, and Tetragon sold approximately 3% of its holdings through this process. The gain in Ripple was driven in part by the tender, as well as an increase in the price of Ripple shares observed in the private market. The valuation of these shares has continued to increase from a series of positive developments, which include the nearing resolution of the SEC's lawsuit with Ripple, significant platform developments, including the launch of XRPL's EVM sidechain, enabling smart contract capabilities, and the pending acquisition of Hidden Road, a global multi-asset prime broker that's expected to close in the third quarter. Additional positive developments include Ripple applying for a national bank charter, which would provide deeper connectivity into the traditional financial system. The announcement, as I said, of the June 2025 tender offer at $175 a share improved regulatory clarity in the U.S. as Congress passed the GENIUS Act governing stablecoin issuance and the progress on the Clarity Act, which would oversee cryptocurrency regulations and the market structure. Lastly, an increase in the XRP token price from $2.10 at year-end to over $3 in mid-July, which established XRP as the third largest cryptocurrency by market capitalization. Combining its balance sheet and escrow holdings, Ripple Labs is the largest owner of XRP. I'm going to cover a few of the other private investments. The second one I want to cover is investments managed by Hawke's Point, TFG Asset Management's resource finance business, which generated realized and unrealized gains of $63 million, which was from their largest strategic investment, an Australian gold mining exploration and development company. Tetragon invested an additional $8 million into Hawke's Point funds and received distributions of $53.3 million during the period. Recently, the company made a strategic investment in an Australian copper producer. Third, investments in Bain & Square Partners portfolio companies generated a gain during the period of $6 million. Bain & Square Partners has 16 positions across its two funds, which include investments across application software, infrastructure software, and cybersecurity. The final category is our PE investments in externally managed private equity funds and co-investment vehicles in Europe and North America. These investments generated gains of $3 million in the first half, and those are spread across 40 different positions. Moving on to the next slide, legal assets. Tetragon makes investments in legal assets through vehicles managed by Contingency Capital. Tetragon has committed capital of $70 million to Contingency, $46 million of which has been called to date, including $5 million during 2025. A gain of $3 million was generated from these investments. The performance of the Contingency Capital Fund 1 and Fund 2 portfolios are above underwritten projections and performance targets, and the performance of these portfolios is not correlated to the public equity and debt markets. Onto the next slide, other equities and credit, and I'm going to cover our cash. Tetragon makes investments directly on its balance sheet, reflecting single strategy ideas. These ideas are either co-investments alongside our TFG Asset Management managers or, at times, idiosyncratic. Each of these investments tends to be opportunistic and with a catalyst. Often, as Patrick Dear mentioned earlier in the presentation, the sourcing of these investments has been facilitated by the managers on the TFG Asset Management platform, as well as third-party managers with whom Tetragon invests. The flexibility to invest in these opportunities is a benefit of Tetragon's structure. This segment generated a gain of $8.2 million during the first half. Finally, Tetragon's cash at bank balance was $3 million as of the end of the first half. That comprised, as I said, the cash at bank, $3 million, $350 million drawn on our credit facility, $90.3 million. This is our net cash I'm covering, $90.3 million due to brokers, net receivables and payables of $108.7 million. A net cash, total net cash of negative $546 million. Tetragon has access to a credit facility of $400 million with a maturity date in 2032. As I mentioned, at the end of the first half, $350 million of that facility was drawn. The liability, as I just covered, is in the net cash balance calculation. Net receivables and payables include the accrued incentive fees for the second quarter, but do not account for the Equitix transaction. Tetragon actively manages its cash levels to cover future commitments and to enable it to capitalize on opportunistic investments and new business opportunities. During the period, Tetragon used cash as follows: $208 million to make investments, $12 million to pay dividends, and $167 million of cash was received as distributions and proceeds from the sale of investments. Future cash commitments are $109 million, comprising investment commitments across BentallGreenOak funds, private equity funds, Tetragon Credit Partners funds, Contingency Capital funds, and working capital loans to certain TFG Asset Management managers. Finally, I want to cover our future investment expectations. First of all, we'll continue to fund commitments to TFG Asset Management. We expect our hedge fund exposure to remain stable. We expect to continue to invest in CLOs via Tetragon Credit Partners vehicles, but we also expect to continue receiving cash back from some of their initial funds. We expect our real estate investments should remain relatively stable because we do have existing investments that are distributing cash. We expect our private equity allocations to keep growing, and there are a few additional LP commitments we've yet to fund. We expect our Bain & Square Partners allocation to continue to grow. In legal assets, as I mentioned earlier, Tetragon will continue funding its commitments to Contingency Capital vehicles and other equities. We expect to continue to invest in these opportunities and for this segment to grow. Lastly, while we're hopeful there'll be additional allocations to make to new asset classes, there's nothing to report at this time. Let me hand it back to Patrick Dear for Q&A. Thanks, Stephen Prince. As you might imagine, everyone, we've had a fair amount of questions, which is great. Thank you very much. What I'm going to try and do is group them into various different themes. The first theme we're going to tackle here is on Ripple Labs, our investment in Ripple Labs. I'm going to read out a few questions, and then we'll collectively take the answer. First question says, "Thank you for the detail on the call. Please, can you discuss your historical purchases, sales, and participation in recent tenders?" The second says, "Can you please talk about how you value the Ripple Labs position?" Third is, "How many shares of Ripple Labs does TFG currently own? What price are you marking the shares based on the $350 million holding in your latest report?" A further question saying, "Other ways to better illustrate the Ripple investment, one of the few public ways to own Ripple Labs?" I think quite a sort of variety of questions there. Maybe start with the basics, and that is, "What do we own and how do we value it?" For that, I'll pass over to Paul. Thank you, Patrick Dear. At June 1, Tetragon owned just over 3.6 million preferred shares in Ripple Labs with an overall valuation of approximately $350 million. The investment in Ripple Labs has been valued using the broker prices observed in private markets. A part of the holding, approximately 3%, was subject to the tender offer that was announced before the end of June and was valued at the tender offer price of $175 per share, with the remaining 97% valued at a share price of just under $94. Thanks, Paul. Tackling sort of going back a bit, which is, "How do we get involved discussing historical purchase and sales, et cetera?" I don't intend to take people through every single transaction, but I think it is useful to answer the question and give a flavor. We first invested in Ripple Labs in 2018, so about seven years ago, and we were buyers of the A and B shares. We ended up rolling those and buying some C shares in 2019. To fast forward to today, we have $263 million invested. We have life-to-date gains of $525 million. That is a sort of total, if you will, of $885 million, of which we've received $438 million in cash. We still have $350 million still invested at the mark that Paul has just discussed. There is a further $21 million we'll expect to receive in July, and that is from the current tender. In summary, we have been buying and selling shares over the years. We do tend to tender into the company tenders that have been done over the last few years and see that as a good source of cash, particularly if they are substantially above the share price. As Paul mentioned, we do see quite an active share price, albeit a private company. It is quite actively traded. The last question here is more about other better ways to illustrate the Ripple Labs investment. I think perhaps what this is driving at is a lot of companies that own crypto have seen an explosion, public companies that own crypto have seen an explosion on the upside in their share price. I think a lot of people have been following MicroStrategy or MicroStrategy, and a lot of people are following the sort of Bitcoin balance sheet transaction. That's not something that we have or we intend to do. I mean, we've looked at it, but it's not something we intend to do. I think we want to be clear to our shareholders and anyone else who's interested about exactly what we own and why. Perhaps if we're missing something in terms of educating people as to what we own and why, we're open to ideas. I think it's clarity that we're looking to achieve. The second theme of questions, not surprisingly again, is about Equitix. Maybe if I read the questions and then tell you how I'm going to try and tackle them. First is, "Why did you not sell all of Equitix?" Secondly, "Do you plan to sell more? What is the timing of the Equitix close and what is the potential use of proceeds?" Is there any sort of put call arrangement with the buyer? I think there are really, you know, and there have been a few other questions. I think there are two. One is the exact facts of the transaction. The second is, when are we going to get the cash and what do we plan to do with it? Maybe if I start by answering the one specific to the Equitix transaction rather than the cash. I would state firstly that our objective for Equitix, and I would state this for all Equitix actually, so it's no different, is to optimize the value to Tetragon over the long term. I say optimize rather than maximize because obviously it does differ over time. We happen to believe that it's an excellent business. It's got an excellent management team. We've really liked the long-term prospects of the business. It's always a trade-off between valuations now versus the future, expected growth. Obviously there's the risk element, it being such a large portion of the portfolio. Where we think we've got to is that by selling this stake to Hunter Point Capital, we think it helps us, A, monetize some of the growth that we've seen over the last 10 years, and de-risk slightly the position in terms of NAV size. It also gets us, we believe, a trusted and excellent partner who will help us grow the business over the years to come and therefore accelerate the growth in the business and hopefully the growth in the NAV. We don't have any specific plans to sell more of Equitix currently, but we will continue to look to optimize the long-term value of the business and thus could and would entertain further sales over the coming years. In terms of the timing for the cash, maybe again I'll hand over to Paul for that one. Sure. I think if I just sort of step back and just talk a little bit about the sort of overall transaction as well, I'll incorporate the timing of the cash into that. As at the end of June, the minority stake, which is subject to sale, which is just roughly 14.6%, was valued at $250 million using the agreed transaction price discounted back to the present value. That whole consideration is in the form of an upfront cash payment. We're currently expecting that to close, although this isn't an exact science, but my best guess would be around the end of Q3, start of Q4. Continuing on the theme of the valuation, the remaining stake, 66.4%, is valued at $1.1 billion. That's using the same methodology that we've used previously, which is a combination of DCF approach and market multiple, with a 70/30 weighting towards the DCF. Handing back over to you, Patrick Dear. Thanks, Paul. Now let's look at the cash. A few questions just for focus. First is, could you please indicate what Tetragon plans to do with the cash proceeds and the most likely timing thereof? Secondly, given the massive undervaluation, about 50% of Tetragon stock, is it a good time now to ask you why you are not buying back your own shares by tender offer or increasing the dividend? A third question here, does management expect to deploy pending realized cash to reduce the current high level of leverage, or is that expected to be addressed only in 2026-2027 when the proceeds of the call put with BentallGreenOak investment? Firstly on the timing of cash, very broadly, we expect that to be in the second half, as Paul has mentioned, approximately $250 million from the Equitix sale. Our current cash position, as Stephen Prince just mentioned, at the end of June was negative $546 million. That does include all liabilities. It does not include the $250 million expected from Hunter Point Capital. If you take the minus $546 million, add in the new cash of $250 million, would leave us with a balance of $300 million debt. We would still be in a net borrowing position. I know that's slightly less than 10% of the NAV of the company, but I don't feel that we'd be awash with cash. The plan would be to pay down debt and then see what our options are. For those of you who have been shareholders for a while, you know we talk about a balance between investments, buybacks, and dividends. I would just point out that in the current environment, if we're looking at buybacks and dividends, there would be a preference for buybacks. I think that is likely to be the case if we continue to trade at a large discount. I would just reiterate something I've said in the past, that the nature of the portfolio has moved from being, in the early days, a very cash-flowing portfolio to what is now a non-cash-flowing portfolio. Therefore, the liquidity tends to be lumpy. We're unlikely to be supporting aggressive growth in dividends that obviously rely on strong levels of cash flow. I would just add a little bit more. There's obviously a question there about share buybacks. Not that we have a lot of cash at the moment or indeed would expect to have a lot of cash this year, but I think it's always worth talking about buybacks. As a lot of people know, we think they're a good use of cash, particularly when the discount is wide. They can obviously therefore be very accretive to NAV per share. I think it's always worth tempering that with, "We don't actually believe they solve the issue of a persistent discount." There's plenty of evidence for that statement, not just with ourselves, but also many other closed-end funds. For historical context, I think it's in the semi-annual, we've spent just under $900 million on buybacks life to date, on top of another approximately $900 million dividend. It is useful, but certainly not a silver bullet in terms of solving discount. Whilst we're talking about the discount, there's a question here, as indeed there should always be, on the discount. It reads as follows: "At this moment, there is a substantial valuation gap between the reported NAV per share and the current share price. I'm wondering which actions management is considering to take to close this gap." The first answer I will give, if you ask anyone in the industry, there is no silver bullet. There's no simple answer to closing the discount. If there were, then hopefully we would have found it because for approximately 17 years, the company's traded at, give or take, a 50%, 60% discount. It is still the right question to ask, "What are we doing?" I've said it in the past, but I continue to say it at its most glib level. I don't mean it to be glib. For the share price to go up, you need to have more buyers than sellers. To achieve more buyers than sellers, you need to have people being enthusiastic about the future growth in the NAV of the business. We still believe, and we'll continue to believe, that that's the single most important objective of the manager, to provide performance on an ongoing basis and hopefully compounding those positive returns. That is, as I say, the single greatest objective, to drive value through that performance. The second thing we do every year is we're trying to focus not just on the performance, but also what is it that drives that performance, i.e., what is the engine, if you will, that we have that drives the performance. The engine we consider to be our ability to generate future performance through idea generation, idea sourcing, underwriting those ideas, investing, risk managing those ideas. That is what we consider to be the engine. If you will, it's the performance, obviously, is the measurement, but trying to hone in that ability to increase the ability to generate future performance. Once we're doing that, I think it's incumbent upon us to explain why we do what we do, how we do what we do, what we do, make sure there's a wider audience as possible, educate the market ourselves, but hopefully leverage our brokers, JPMorgan and Jefferies, and indeed others. It's about the quality of the reporting, these calls, the annual, the monthlies, the websites, et cetera. Of course, relevant is dividends and buybacks, which I tackled a moment ago. Moving on, we have a question on, a question was alluded to in there about BentallGreenOak and thought it was worth just sort of mentioning where we are on timing of the put call and how it works. I'm going to pass over to Paul for that one. Yes, thank you, Patrick Dear. When Sun Life acquired a majority stake in Green Oak in 2019, Tetragon, through TFG Asset Management, retained a stake of just under 13% in the business. Sun Life, as part of that transaction, has a call agreement, which is exercisable in 2026, with the key inputs being the BentallGreenOak EBITDA in 2024 and 2025. If that call is exercised, which we currently expect that it will, though it's obviously not 100% certain, we expect this to take place in the first half of 2026. If, for whatever reason, Sun Life does not exercise that call, Tetragon owns a put, which is largely identical to the call except it references the 2025 and 2026 EBITDA as its key inputs, and that would be exercisable in 2027. Thanks very much. There's a question here on the CLO part of the portfolio. What were the main drivers of the $23.8 million loss on the bank loans portfolio? Firstly, I would say that is split between LCM Advisors, CLOs, and Tetragon Credit Partners funds. You can see the actual split on figure 10 in the semi-annual, $16.7 million in losses at LCM and approximately $7 million across the TCP funds. The answer there is both realized and unrealized losses in the underlying credits of those CLOs in the first half. There is one question here on Hawke's Point, which is, "How is Hawke's Point progressing? Do they still have an investment in Capricorn Resources?" If I answer that in reverse, Capricorn Resources, we exited in 2022. No, we don't still have, or they don't still have, an investment in Capricorn. As to how it is progressing, I think the best indication or the best way to monitor that, again, is that figure 10 that I just referred to in the last question. That shows the NAV and the performance for Hawke's Point funds. You can see there that in the last six months, it made $62 million of profit, which Stephen Prince talked a little bit about, and total NAV invested is $216 million. If you were to go back over the quarterlies and the annuals and the semi-annuals, you could track that. The answer is very healthy performance over the last several years. One question here just on life sciences. As I gather, you are investing more in life sciences. Can you tell us a little bit more about it? The answer is yes. It's very early days, so we don't break it out in figure 10 as a separate investment area. We have a small team, Boston-based. Currently, we have $31 million invested across 16 positions. Had a P&L in the first half of positive $2 million. A good start. When we get it to being a larger portion of the NAV, we'll break it out separately in that figure 10. I think that takes us to the end of questions. I am going to leave it there. Thank you very much for joining. I hope you all have a good summer. Thank you. Thank you. This now concludes our presentation. Thank you all for attending. You may now disconnect.